Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to 0.11.

  • Ptc Therapeutics' Debt Ratio fell 6323.71% to 0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.11, marking a year-over-year decrease of 6323.71%. This contributed to the annual value of 0.32 for FY2024, which is 2621.71% up from last year.
  • Ptc Therapeutics' Debt Ratio amounted to 0.11 in Q3 2025, which was down 6323.71% from 0.21 recorded in Q2 2025.
  • In the past 5 years, Ptc Therapeutics' Debt Ratio registered a high of 0.54 during Q3 2023, and its lowest value of 0.11 during Q3 2025.
  • Moreover, its 5-year median value for Debt Ratio was 0.24 (2022), whereas its average is 0.28.
  • In the last 5 years, Ptc Therapeutics' Debt Ratio surged by 13553.62% in 2023 and then plummeted by 6323.71% in 2025.
  • Over the past 5 years, Ptc Therapeutics' Debt Ratio (Quarter) stood at 0.22 in 2021, then surged by 69.58% to 0.38 in 2022, then crashed by 33.13% to 0.25 in 2023, then grew by 26.22% to 0.32 in 2024, then plummeted by 66.01% to 0.11 in 2025.
  • Its last three reported values are 0.11 in Q3 2025, 0.21 for Q2 2025, and 0.2 during Q1 2025.